The appearance of abnormal neurological signs in children with leukaemia in haematological remission may be due to the post-irradiation syndrome!' or methotrexate toxicity"' in the early months of treatment and meningeal leukaemia, haemorrhage, or infection of the central nervous system at any stage. The histological appearance of the brain in our case of measles encephalopathy resembled neither the appearances in acute measles encephalitis nor those in SSPE. There was a surprising absence of perivascular inflammatory cells, and the predominating features were focal neuronal loss, spongy changes, and gliosis, with many nuclear and cytoplasmic inclusion bodies in some areas and none in others. Similar appearances have been described previously.' Hence possibly some of the cases of encephalopathy that have been recorded in children with leukaemia may have resulted from measles infection without obvious inclusion bodies being seen in the brains of those who reached necropsy.l''1 3 Lesions produced in the brains of monkeys by intracerebral and intranasal inoculation with different viruses can be modified by concurrent administration of cyclophosphamidel 4 ; animals given immunosuppressive therapy showed not only increased invasiveness of the viruses but also the replacement of the expected cerebral inflammatory changes by a degenerative process causing neuronal necrosis and spongy degeneration.
Conclusions and recommendations
In children on immunosuppressive treatment primary measles infection may present with very atypical clinical pictures. The incubation period may be prolonged, there may be no rash or a rash that lasts for weeks, and the illness may be mild or very severe. Commonly used doses of pooled immunoglobulin may fail to protect against measles infection and may further confuse the diagnosis by modifying the illness. Two doses of 1500 mg at an interval of 48 hours are recommended by the Public Health Laboratory Service for children over three years of age on immunosuppressive treatment.
In the giant-cell pneumonia resulting from measles infection the virus may persist in nasophrayngeal secretions for three weeks or more. In either giant-cell pneumonia or encephalpathy after measles infection antibody formation in the blood is unpredictable, and may be low or absent even when measles virus is present in profusion in the lungs or brain. Nevertheless, measles antibodies should be sought when leukaemia is first diagnosed and repeatedly in serum or cerebrospinal fluid in any unusual respiratory infection or encephalopathy during the course of cytotoxic treatment.
The histological picture resulting from invasion of the brain by measles virus resembles neither the acute inflammatory appearances seen in post-measles encephalitis nor those of SSPE. An appropriate term might be "immunosuppressive measles encephalopathy."
Repeated large doses of pooled immunoglobulin may have some beneficial effect in measles giant-cell pneumonia, but since no treatment is effective in measles encephalopathy every effort should be made to prevent measles infection. Nonimmune siblings should' be immunised and segregated from the patient for a fortnight.
HLA-linked genes and islet-cell antibodies in diabetes mellitus There was no association between the presence of ICA and any particular HLA phenotype. Within families containing two or more HLA haploidentical siblings with juvenile onset diabetes ICA was a variable finding both in its occurrence and in its relation to the duration of disease.
A possible mode of action for the HLA-linked gene may be to permit a rapid immunological destructive process, possibly associated with viral infection.
Introduction
Recent studies have produced evidence that susceptibility to juvenile onset or insulin-dependent diabetes is associated with particular HLA phenotypes,'-3 there being a twofold to three- Immunofluorescent methods-ICA and thyroid and gastric antibodies were detected as described. 9 The titres of positive sera were measured in doubling dilutions starting at 1/5. Sheep polyvalent antihuman immunoglobulin (Wellcome Laboratories) was the second layer in all tests, which were performed using coded sera.
Results

ISLET-CELL ANTIBODIES
The prevalence of ICA in relation to the duration of diabetes for the three categories of diabetic subjects is shown in table I. Overall ICA occurred in 38 out of 209 patients (180o0). Thirty-three of these were among the 139 insulin-dependent patients with juvenile onset diabetes (24%). In this latter group were 27 patients who had had diabetes for less than one year, 16 of whom were ICA positive (590os).
In the second year of duration seven out of 13 Thyroid microsomal or gastric parietal cell antibodies, or both, were detected in 45 of the 139 patients with juvenile onset diabetes (32'i ); these antibodies occurred in 17 of the 33 ICA-positive individuals in this group. Thyroid or gastric antibodies, or both, occurred in 15 of the 51 patients with maturity onset diabetes (29%,) and in seven of the 19 insulin-dependent subjects with diabetes of late onset (37`y).
When the three groups of diabetic patients were considered together, thyrogastric antibodies occurred in 43 out of 119 patients who had HLA-B8 or BW 15, or both, compared with 24 out of 90 subjects with other HLA types. These differences were not significant (y2 = 17; P > 01). There was no association between the presence of thyroid and gastric antibodies and any other particular HLA phenotvpe.
Discussion
The high prevalence of ICA in recently diagnosed insulindependent diabetics is again confirmed by the present study. ICA probably appears in most patients during the initial stages of development of this type of diabetes but decreases thereafter. In a few cases, however, antibodies may be detected as long as 37 years after the onset of symptoms.
No data have been reported concerning ICA in a random series of patients not dependent on insulin. In our 51 such cases, which included several recently diagnosed, only one positive low-titre result was found, and it therefore seems unlikely that humoral autoimmunity to islet cells plays any part in the pathogenesis of maturity onset diabetes.
A major factor determining susceptibility to juvenile diabetes is the presence of a diabetogenic gene or genes at a locus closely linked to the HLA loci.," Data on the diabetic population suggest that this gene occurs about twice as often on HLA chromosomes with alleles for HLA-B8 and BW 15 as on other homologous chromosomes (linkage disequilibrium). The mode of action of such genes remains speculative, but interactions with receptors for viruses and other pathogens and association with immune response genes have been suggested.'0 Possibly the effect of the gene or genes is mediated by ICA. If there is only one such gene then all juvenile diabetics would be expected to have ICA, and no association with a particular HLA phenotype would be found. Conceivably at an early stage of their disease process most, if not all, insulin-dependent diabetics do have circulating ICA. Similarly, if ICA is the usual consequence of islet-cell damage of any cause no association between ICA and any particular HLA phenotype would occur. We found no such association, which is consistent with either hypothesis. The possibility that a gene associated with a particular HLA allele might be responsible for the prolonged persistence of ICA in a subgroup of diabetics is unlikely since there was no significant correlation between demonstrable ICA and HLA phenotypes in either recent or long-standing cases.
With regard to the family studies it has been shown that when there are two siblings with juvenile onset diabetes in a family the development of diabetes is dependent on inheritance of at least one identical HLA chromosome.8 If the mechanism of action of the diabetogenic gene on this chromosome implicates ICA production the affected siblings would be expected to show similar ICA results. Our study shows little evidence of such uniformity. In four of the families, however, ICA may have disappeared in the siblings with the longer duration of diabetes, and the observed variation in ICA in siblings may simply reflect differing rates of disease activity and antibody disappearance.
It remains speculative whether the genetic susceptibility to juvenile onset diabetes depends on immunological mechanisms including ICA production. But a possible mode of action for the HLA-linked gene may be to permit a rapid immunological destructive process, by analogy with lymphocytic choriomeningitis virus encephalitis in-mice, in which the disease probably depends on the development of an immune response to the virus and is determined by a gene in the histocompatibility (H2) region.1' Further studies of the possible cytotoxic role of ICA and of cellular immune mechanisms that may cause islet-cell damage may throw light on this important problem.
